Madelyn Burkart

14PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 22, 2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.

Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko

|Feb 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Talha Badar, Ehab Atallah, Rory Shallis

|Dec 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.

Talha Badar, Mark R Litzow, Rory M Shallis

|Dec 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova

|May 16, 2022
Ibrutinib Plus R-ICE Induces Remission in Blastoid Variant Mantle Cell Lymphoma with CNS Relapse.

Timothy S Oh, Madelyn Burkart, Amir Behdad

|Mar 25, 2022
Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors.

Madelyn Burkart, Reem Karmali

Pageof 3

Frequent Collaborators

4 joint publications

Reem Karmali

4 joint publications

Anand Patel

4 joint publications

Talha Badar

3 joint publications

Brad S Kahl